The Department of Obstetrics and Gynecology is made up of five different divisions: Gynecology, Maternal Fetal Medicine, Reproductive Endocrinology and Infertility, Gynecologic Oncology, and Women’s Health. The faculty of this department provide expertise in the areas of education, research and clinical care relating to the disciplines of both obstetrics and gynecology.

Faculty members teach residents in obstetrics and gynecology and fellows in the four subspecialties approved by The American Board of Obstetrics and Gynecology: gynecology oncology, maternal fetal medicine, reproductive endocrinology and infertility, and female pelvic medicine and reconstructive surgery.

Gynecology »
The Gynecology division represents the best in education, research, and clinical care for all benign gynecologic conditions.

Maternal Fetal Medicine »
The Division of Maternal-Fetal Medicine is one of the leading divisions in the country in research and training has trained more fellows than any other program in the country. From its training and research base at LAC+USC Women’s and Children’s Hospital, the nine members of the USC Perinatal Group maintain a busy consultation practice throughout the central Los Angeles, Glendale and Burbank area.

Reproductive Endocrinology »
The Division of Reproductive Endocrinology and Infertility is among the nation’s pre-eminent clinical research organizations. Faculty members of the division have won numerous research awards in all areas of Reproductive Medicine, from infertility to menopause, from hypogonadism to ovarian hyperstimulation. A leader in clinical medicine as well as research, the division is home to one of the most productive Fellowship programs, having trained over 68 sub-specialists in Reproductive Endocrinology and Infertility.

Gynecologic Oncology »
Gynecologic oncology involves the surgical treatment and chemotherapy administration for women with gynecologic cancers ( uterus, ovary, cervix, vulva, and vagina). Pre cancers in these organs are also diagnosed and treated with a goal to prevent progression. Ongoing active research is being aggressively pursued for clinical and preclinical studies.